Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Newly Institute is a Canadian mental health and wellness company operating a network of purpose-built outpatient clinics focused on mental health, addiction, trauma, and chronic pain. The company provides medically managed intensive outpatient programs, psychotherapy, occupational therapy, and medically assisted therapy, including ketamine treatment when clinically indicated. Its care model emphasizes rapid access, intensive multidisciplinary treatment, and return-to-function outcomes for patients including first responders, veterans, healthcare workers, and the broader community. The company appears to operate as a service provider rather than a traditional drug-development biotech, with proprietary clinical protocols and clinic-based programming rather than a disclosed pharmaceutical pipeline. It is active across multiple Canadian provinces and continues to expand its clinic footprint and programming.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Newly Institute.